Cardiome Selects Quintiles To Manage Global Regulatory Affairs And Life Cycle Safety Activities For BrinavessTM (Vernakalant Intravenous)

[at noodls] – Vancouver, Canada, February 4, 2013 — Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced the selection of Quintiles to provide comprehensive post-marketing lifecycle safety and global regulatory … more

View todays social media effects on CRME

View the latest stocks trending across Twitter. Click to view dashboard

See who Cardiome is hiring next, click here to view